Comments
Dr Reddy’s Laboratories announced today that it launched Paricalcitol capsules, 1 mcg, 2 mcg and 4 mcg, a therapeutic equivalent generic version of ZEMPLAR® (Paricalcitol) Capsules in the US market on Tuesday (June 24), following approval from the United States Food & Drug Administration (USFDA).
The Zemplar brand and its generic version recorded US sales of approximately $109.6 million for the most recent 12 months ending in March 2014, according to IMS Health.
Dr Reddy’s Paricalcitol capsules are available in bottle counts of 30.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.